Valganciclovir RC A:
2-Amino-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-1,9-dihydro-6H-purin-6-one ; CAS : 82410-32-0 ; C9H13N5O4 ; Mol. Wt.: 255.23 ; |
Valganciclovir RC B:
2-Amino-1,9-dihydro-6H-purin-6-one ; CAS : 73-40-5 ; C5H5N5O ; Mol. Wt.: 151.13 ; |
Valganciclovir RC C:
2-Amino-1,9-dihydro-9-(methoxymethyl)-6H-purin-6-one ; CAS : 1202645-50-8 ; C7H9N5O2 ; Mol. Wt.: 195.18 ; |
Valganciclovir RC E:
2-((2-Amino-6-oxo-1,6-dihydropurin-9-yl)methoxy)-3-hydroxypropyl acetate ; CAS : 88110-89-8 ; C11H15N5O5 ; Mol. Wt.: 297.27 ; |
Valganciclovir RC F:
2-[(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-1,3-bis[(S)-2-amino-3-methylbutyryl]propane ; C19H31N7O6 ; Mol. Wt.: 453.49 ; |
Valganciclovir RC G:
L-Valine 2-[[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]methoxy]-3-hydroxypropyl ester ; C15H24N6O6 ; Mol. Wt.: 384.39 ; |
Valganciclovir RC N :
N-Methyl-L-valine 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester HCl ; CAS : 1401562-16-0 ; C15H25ClN6O5 ; Mol. Wt.: 404.85 ; |